Create stable, long-term investment portfolio with strong, consistent stocks.
Start Research-backed Investing ...Now.
Wintac is currently trading at Rs. 268.00, up by 1.00 points or 0.37% from its previous closing of Rs. 267.00 on the BSE.
The scrip opened at Rs. 267.00 and has touched a high and low of Rs. 268.00 and Rs. 267.00 respectively. So far 4744 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 268.00 on 24-Jul-2017 and a 52 week low of Rs. 130.00 on 15-Nov-2016.
Last one week high and low of the scrip stood at Rs. 268.00 and Rs. 251.00 respectively. The current market cap of the company is Rs. 268.65 crore.
The promoters holding in the company stood at 54.99%, while Institutions and Non-Institutions held 0.01% and 45.00% respectively.
Wintac has received an approval for issue of 66.83 lakh equity shares on Rights basis to the existing shareholders of the company in the ratio of 3 : 2 i.e., 2 (two) shares for every 3 (three) shares held at a price of Rs 100 per share (Rs10 face value + Rs 90 premium per share) aggregating to Rs 66.83 crore.
The funds raised would be utilised to meet the capital expenditure on construction of New Manufacturing Facility and other corporate funds requirements and also to augment the long term working capital of the company. The board of directors at their meeting held on July 27, 2017, has approved for the same.
Wintac’s range of specialties includes Antifungal, Anticancer, Cardiovascular, Corticosterid , Antiemetic, Large and small volume injectable and Ophthalmic solutions. The company has also forayed into the field of critical care by manufacturing and marketing products targeted to the critically ill patients.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1531.35 |
| Dr. Reddys Lab | 5797.65 |
| Cipla | 1402.15 |
| Zydus Lifesciences | 1031.15 |
| Lupin | 1652.00 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
